GNGT1 Human

Guanine Nucleotide Binding Protein Gamma Transducing 1 Human Recombinant
Cat. No.
BT13425
Source
Escherichia Coli.
Synonyms
Guanine Nucleotide Binding Protein (G Protein), Gamma Transducing Activity Polypeptide 1, Transducin Gamma Chain, Guanine Nucleotide-Binding Protein G(T) Subunit Gamma-T1, GNG1, Guanine nucleotide-binding protein G(T) subunit gamma-T1.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

GNGT1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 94 amino acids (1-71 a.a) and having a molecular mass of 10.6kDa.
GNGT1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Guanine Nucleotide Binding Protein Gamma Transducing 1, also known as GNGT1, is a member of the G protein gamma family. GNGT1 is involved in various transmembrane signaling systems, acting as a modulator or transducer. Additionally, GNGT1 (beta & gamma chains) is essential for GTPase activity, the exchange of GDP for GTP, and interactions between G proteins and their effectors.
Description
Recombinant human GNGT1, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 94 amino acids (1-71 a.a). It has a molecular weight of 10.6 kDa. The protein is fused to a 23-amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Sterile, colorless solution.
Formulation
GNGT1 protein solution (1 mg/mL) in 20 mM Tris-HCl buffer (pH 8.0), 10% glycerol, 0.1 M NaCl, and 1 mM EDTA.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For long-term storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Greater than 95.0% purity as determined by SDS-PAGE.
Synonyms
Guanine Nucleotide Binding Protein (G Protein), Gamma Transducing Activity Polypeptide 1, Transducin Gamma Chain, Guanine Nucleotide-Binding Protein G(T) Subunit Gamma-T1, GNG1, Guanine nucleotide-binding protein G(T) subunit gamma-T1.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMPVINIE DLTEKDKLKM EVDQLKKEVT LERMLVSKCC EEVRDYVEER SGEDPLVKGI PEDKNPFKEL KGGC.

Product Science Overview

Introduction

Guanine Nucleotide Binding Protein Gamma Transducing 1 (GNGT1) is a crucial component of the heterotrimeric G protein complex, which plays a significant role in various cellular signaling pathways. This protein is particularly important in the visual signal transduction pathway in rod photoreceptor cells.

Gene and Protein Structure

The GNGT1 gene encodes the gamma subunit of transducin, a guanine nucleotide-binding protein (G protein) found in rod outer segments . The transducin protein is composed of three subunits: alpha, beta, and gamma. The gamma subunit, encoded by GNGT1, is essential for the proper functioning of the transducin complex .

Function

Transducin, also known as GMPase, mediates the activation of a cyclic GTP-specific (guanosine monophosphate) phosphodiesterase by rhodopsin . This process is crucial for the conversion of light signals into electrical signals in the retina, enabling vision. The gamma subunit of transducin is involved in the GTPase activity, replacement of GDP by GTP, and interaction with G protein effectors .

Pathways and Interactions

GNGT1 is involved in several signaling pathways, including:

  • ADORA2B mediated anti-inflammatory cytokines production
  • Thromboxane signaling through TP receptor

These pathways highlight the broader role of GNGT1 beyond visual signal transduction, indicating its involvement in various physiological processes.

Clinical Significance

Mutations or dysregulation of the GNGT1 gene have been associated with several diseases, including:

  • Prostate Cancer
  • Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2B

Understanding the role of GNGT1 in these diseases can provide insights into potential therapeutic targets and treatment strategies.

Recombinant GNGT1

Human recombinant GNGT1 is produced using recombinant DNA technology, which involves inserting the GNGT1 gene into a suitable expression system, such as bacteria or yeast, to produce the protein in large quantities. This recombinant protein is used in various research applications to study its function, interactions, and role in disease.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.